When was Psyomics founded?

Psyomics was founded in 2015 and raised its 1st funding round 1 year after it was founded.

Where is Psyomics located?

Psyomics is headquartered in Cambridge, United Kingdom. It is registered at 7 QUY COURT COLLIERS LANE,STOW-CUM-QUY,CAMBRIDGE,ENGLAND,CB25 9AU.

Which legal entities is Psyomics associated with?

Psyomics is associated with PSYOMICS LTD and 1 other.

How many employees does Psyomics have?

As of Aug 31, 2026, the latest employee count at Psyomics is 26.

Is Psyomics a funded company?

Psyomics is a funded company, having raised a total of $15.4M across 9 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Mar 01, 2016.

How much is Psyomics worth?

The latest valuation of Psyomics is £***** as of Apr 29, 2024.

When was the latest funding round of Psyomics?

Psyomics' latest funding was a $***** Conventional Debt round on Jul 28, 2026, with participation from 1 investor.

Where does Psyomics rank among its competitors?

Psyomics ranks 2nd amongst 117 active competitors, of which 16 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was Onos Health, which secured $17M in Aug, 2026.

Who are the top competitors of Psyomics?

Psyomics' top competitors include Frontera Health, Onos Health and DAS Health. Among them, Onos Health secured the most recent funding round in August, 2026.

Psyomics - 2026 Company Profile, Team, Funding, Competitors & Financials

Psyomics is a series B company based in Cambridge (United Kingdom), founded in 2015 by Sabine Bahn and Daniel Cowell. It operates as a Provider of app for mental health diagnostics in workplace and clinical trials. Psyomics has raised $15.4M in funding from Parkwalk and Parkwalk, with a current valuation of £*****. The company has 117 active competitors, including 16 funded and 3 that have exited. Its top competitors include companies like Frontera Health, Onos Health and DAS Health.

Company Details

Provider of app for mental health diagnostics in workplace and clinical trials. It is developing a digital platform for mental health diagnostics. It offers diagnostic tool that combines biological information with digital information collected through a web based app in the form of questionnaires. It provides personalized insights, education, and advice for employees on mental health issues.

Website: www.psyomics.com/
Social
Email ID: *****@psyomics.com
Registered Address: 7 QUY COURT COLLIERS LANE,STOW-CUM-QUY,CAMBRIDGE,ENGLAND,CB25 9AU

Key Metrics

Founded Year

2015

Location

Cambridge, United Kingdom

Stage

Series B

Total Funding

$15.4M in 9 rounds

Latest Funding Round

Conventional Debt, Jul 28, 2026, $*****

Post Money Valuation

£***** as on Apr 29, 2024

Investors

Parkwalk & 17 more

Ranked

2^nd among 117 active competitors

Employee Count

26 as on Aug 31, 2026

Similar Companies

Frontera Health & 143 more

View Psyomics' full profile

Psyomics is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
PSYOMICS LTD CIN: 9470381 , United Kingdom, Active	Mar 03, 2015	-	-
PSYOMICS LIMITED CIN: 09470381 , United Kingdom, Active	Mar 03, 2015	-	14 (As on Dec 31, 2023)

Psyomics has raised a total funding of $15.4M over 9 rounds. Its first funding round was on Mar 01, 2016. Its latest funding round was a Conventional Debt round on Jul 28, 2026 for $*****. 1 investor participated in its latest round. Psyomics has 14 institutional investors and 4 angel investors.

Here is the list of recent funding rounds of Psyomics:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 28, 2026	2339108	Conventional Debt	9922798	3251162	4708150	6982289
Mar 26, 2024	8690246	Series B	1560582	2527396	1003902	5824116
Jan 17, 2022	6474286	Series B	8635500	6341070	Parkwalk	Meltwind Advisory & 1 more

Access funding benchmarks and valuations. Sign up today!

View details of Psyomics's funding rounds and investors

The founders of Psyomics are Sabine Bahn and Daniel Cowell. Melinda R is the CEO of Psyomics.

Here are the details of Psyomics' key team members:

Sabine Bahn: Co-Founder of Psyomics. They are also an angel investor in 1 startup and serve on the board of 1 company.
Daniel Cowell: Former Co-Founder of Psyomics. They are also an angel investor in 1 startup.
Melinda R: CEO of Psyomics.

Psyomics' Board of Directors

Psyomics's board has 4 active members. Sabine Bahn is part of team and Melinda Rees, Kevin Edward Martin Mcdonnell and Dr Michelle Elizabeth Tempest are independent board members.

Here is the list of Psyomics' board of directors:

Name	Type	Representing	Status	Duration
Sabine Bahn	Team	-	Current	11y 6m
Melinda Rees	Independent board member	-	Current	2y 11m
qtxqxfa	Independent board member	-	Current	5y 9m
vqvgxto	Independent board member	-	Current	1y 3m

View details of Psyomics's Founder profiles and Board Members

Psyomics' employee count trend

Psyomics has 26 employees as of Aug 26. Here is Psyomics's employee count trend over the years:

Uncover Psyomics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Psyomics include Frontera Health, Onos Health and DAS Health. Here is the list of Top 10 competitors of Psyomics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Frontera Health 2023, Denver (United States), Seed	Provider of AI-powered software automating ABA clinical report writing	$42M	Lightspeed Venture Partners, Lux Capital & 3 others	58/100
2nd	Psyomics 2015, Cambridge (United Kingdom), Series B	Provider of app for mental health diagnostics in workplace and clinical trials	$15.4M	Cambridge Angels, University of Cambridge ... & 16 others	55/100
3rd	Onos Health 2024, San Francisco (United States), Series A	Provider of a behavioral health platform for payers	$23.3M	Costanoa, Haystack & 5 others	54/100
4th	DAS Health 2003, Tampa (United States), Acquired	Healthcare IT solutions and services to streamline operations and improve care	-	Fifth Third Bank, Sheridan	51/100
5th	Spectrum AI 2021, Los Angeles (United States), Acquired	AI-enabled behavior analysis tool for autism	$29M	F-Prime Capital, Frist Cressey Ventures & 3 others	50/100
6th	i-spero 2018, Wallingford (United Kingdom), Unfunded	Provider of AI-based software for the diagnosis of depression	-	-	42/100
7th	Cerebra 2015, Winnipeg (Canada), Seed	Sleep analysis and diagnostic tool for clinicians and researchers	$2.5M	MedTech Innovator	41/100
8th	Ped(z) 2008, Germany, Unfunded	Digital pediatric calculator for pediatrics	-	-	40/100
9th	ASD Tests 2017, Albany (New Zealand), Unfunded	Digital Autism Spectrum Disorder (ASD) tests tool	-	-	38/100
10th	Evidence-Based Behavior 2017, Madrid (Spain), Seed	Provider of an AI-based app for evaluating patient mental behaviour	-	Ship2B, EIC Fund & 2 others	37/100